COMP <GO>
CLBT vs AAPL // EV/EBITDA & P/E VALUATION
Cellebrite DI Ltd. (NASDAQ) VS. Apple Inc. (NASDAQ) • 15-METRIC TALLY: CLBT 4
— AAPL 9
▲ EV/EBITDA & P/E VALUATION LEADER: AAPL
LAST: $12.28 (+3.02%) • MKT CAP: $3.09B
valuation
38.1x
LAST: $348.91 (+1.48%) • MKT CAP: $5.09T
valuation
30.1x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CLBT VS. AAPL)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CLBT | AAPL | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 84.20% | 48.65% | +35.55 | CLBT | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 14.60% | 81.38% | -66.78 | AAPL | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 38.1x | 30.1x | +7.99 | AAPL | /valuation <GO> |
| Free Cash Flow Yield | 5.19% | 2.72% | +2.47 | CLBT | /fcf-yield <GO> |
| Operating Margin | 14.00% | 33.17% | -19.17 | AAPL | /operating-margins <GO> |
| Net Profit Margin | 16.50% | 27.62% | -11.12 | AAPL | /net-margins <GO> |
| Revenue Growth (YoY) | 18.60% | 14.24% | +4.36 | CLBT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.31% | -0.31 | AAPL | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.95 | 13.54 | -8.59 | AAPL | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 9/9 | -1.00 | AAPL | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 5.76% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 58.1 | 66.6 | -8.48 | AAPL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.14 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 33.1x | 35.3x | -2.24 | CLBT | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.09B | $5.09T | -$5.09T | AAPL | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CLBT REV | AAPL REV | CLBT GROSS % | AAPL GROSS % | CLBT FCF | AAPL FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $475.7M | $416.16B | 84.2% | 46.9% | $160.3M | $98.77B |
| FY 2024 | $401.2M | $391.04B | 84.4% | 46.2% | $123.6M | $108.81B |
| FY 2023 | $325.1M | $383.29B | — | 44.1% | $102.1M | $99.58B |
| FY 2022 | — | $394.33B | — | 43.3% | — | $111.44B |
| FY 2021 | — | $365.82B | — | 41.8% | — | $92.95B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CLBT // BETA —
AAPL // BETA 1.14